Search clinical trials for: NuSepin® 0.2 mg
Total 2021 results
-
ShaperonCompletedCOVID19 PneumoniaRomania
-
ShaperonRecruiting
-
H. Lundbeck A/SCompleted
-
Sichuan Haisco Pharmaceutical Group Co., LtdThe First Hospital of Jilin UniversityCompletedHealthy Elderly SubjectsChina
-
AsclepiX Therapeutics, Inc.TerminatedDiabetic Macular Edema (DME)United States
-
AsclepiX Therapeutics, Inc.TerminatedNeovascular Age-Related Macular Degeneration (nAMD)United States
-
Kowa Company, Ltd.Completed
-
Kwang Dong Pharmaceutical co., ltd.Completed
-
University of Texas Southwestern Medical CenterUS Department of Veterans AffairsCompletedRectal CancerUnited States
-
Gangnam Severance HospitalCompleted
-
Andrew J. Armstrong, MDCompletedProstate CancerUnited States
-
Kowa Company, Ltd.Completed
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompleted
-
Autoimmune Technologies, LLCCompleted
-
Oyster Point Pharma, Inc.Completed
-
Cara Therapeutics, Inc.CompletedPruritus | Atopic DermatitisUnited States, Canada
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...RecruitingHypertension, PulmonaryUnited States, Belgium, France, Germany, Israel, Italy, Spain, Sweden, United Kingdom, Poland, Canada
-
Atox Bio LtdTerminatedAcute Kidney Injury | Peritonitis | Necrotizing Soft Tissue InfectionUnited States, France
-
KBP BiosciencesWorldwide Clinical TrialsCompletedHypertension | Chronic Kidney DiseasesUnited States
-
AM-PharmaCompleted
-
Auris Medical AGCompleted
-
Novo Nordisk A/SCompleted
-
Georgetown UniversityCompletedPeripheral Vascular DiseaseUnited States
-
Kati JärveläFinnish Cultural FoundationCompletedFluid Volume DisorderFinland
-
Cara Therapeutics, Inc.Terminated
-
Aristotle University Of ThessalonikiEugonia IVF Unit, Athens, GreeceUnknown
-
MedImmune LLCAstraZenecaTerminatedLupus Erythematosus, SystemicUnited States, Mexico, Peru, South Africa, Canada
-
Atox Bio LtdBiomedical Advanced Research and Development AuthorityCompletedNecrotizing Fasciitis | Necrotizing Soft Tissue Infections | Fournier's GangreneUnited States, France
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States
-
University of PatrasCompletedPostoperative Pain | Morbid Obesity | Postoperative Bowel Function | Postoperative AmbulationGreece
-
GlaxoSmithKlineCompleted
-
Biomedisyn CorporationYale UniversityCompleted
-
GlaxoSmithKlineCompleted
-
Zogenix International Limited, Inc., a subsidiary...CompletedDravet Syndrome | Lennox Gastaut SyndromeUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
SIFI SpACompletedAcanthamoeba KeratitisItaly, United Kingdom, Poland
-
University of MichiganCompleted
-
Zogenix International Limited, Inc., a subsidiary...Active, not recruitingLennox Gastaut SyndromeUnited States, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Mexico, Netherlands, Poland, Spain, Sweden
-
Oyster Point Pharma, Inc.CompletedLong Term Follow up Dry Eye DiseaseUnited States
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
Merck Sharp & Dohme LLCCompleted
-
Kowa Company, Ltd.Completed
-
Cara Therapeutics, Inc.CompletedChronic Kidney Diseases | PruritusUnited States
-
CelgeneCompleted
-
Alcon ResearchCompletedVitreomacular Traction | Vitreomacular AdhesionAustralia
-
Yuhan CorporationTerminatedFunctional DyspepsiaKorea, Republic of
-
University of RostockCompletedObservation of Neuromuscular Block | Complication of Ventilation TherapyGermany
-
Cubist Pharmaceuticals LLCCompleted
-
Idera Pharmaceuticals, Inc.CompletedWaldenstrom's Macroglobulinemia